Yahoo Web Search

  1. Ads
    related to: plaque psoriasis treatment
    • Update on U.S. FDA Review of Biologics License Application

      Law.com· 6 days ago

      ... and Drug Administration (FDA) has informed the Company that they were unable to complete review of the Biologics License Application (BLA) for bimekizumab for the treatment of moderate to severe plaque psoriasis by the Prescription Drug User Fee Action (PDUFA) date of Oc

  1. Ads
    related to: plaque psoriasis treatment